Current MEG Announcements
Plan to attend the MEG events at the AACR Annual Meeting 2020
Reserve your Epidemiology Consortium Meeting Room at the AACR Annual Meeting 2020!
For the eighth consecutive year, the AACR-MEG Leadership is pleased to provide MEG members with this benefit, free-of-charge. The room will be scheduled on a first-come, first-served basis. For further details and how to apply, see here. DEADLINE for application is Thursday, April 9, 2020. We look forward to accommodating your meeting!
MEG Special Networking Session with CIMM (Immunology working Group): Intersection of immunology & Epidemiology at the AACR Annual Meeting 2020
Monday, April 27, 2020, 5:15-6:16 p.m. (just prior to the MEG Town Hall)
San Diego Convention Center, Plaza (outside tent area off of Plenary Hall)
Come join leaders from the immunology and epidemiology fields and contribute your ideas on how to bring these exciting fields together, as well as the key breakthroughs and educational opportunities that exist at the intersection of these two disciplines in a fast-paced, world cafe-style networking session. The following questions will be addressed: Topic 1: How to bring immunology and epidemiology together? What are the most pressing research questions that can be addressed by the fields of immunology and epidemiology together? What are the challenges of bringing immunology to population-based studies? Technologies, etc.? Topic 2: Key Breakthroughs/Critical Topics for discussion at AACR Special Conference: Consider the key breakthroughs for immunoepidemiology research. What are the critical topics to discuss at a workshop or AACR session? Are there important educational/methods sessions that should be included at an AACR meeting or AACR Special Conference?
Apply NOW for the AACR integrative molecular epidemiology workshop 2020!
Applications are now being accepted for the Integrative Molecular Epidemiology Workshop: “Bridging Cancer Biology & Precision Medicine”, being held July 27-31, 2020 at the Westin Copley Place in Boston, Massachusetts! This workshop is designed to accelerate the training of the Next-Generation of Cancer Researchers. Deadline for application is 11:59 p.m. ET-USA on Monday, April 13, 2020. For further details on this Workshop and how to apply, see here.
Fifth International Molecular Pathological Epidemiology (MPE) Meeting, June 4-5, 2020, Dana-Farber Cancer Institute, Boston, Massachusetts
Drs. Shuji Ogino; Christine Ambrosone; Peter T. Campbell; Montserrat Garcia-Closas; and Timothy Rebbeck, Cochairs, cordially invite you to participate in this Meeting which is free-of-charge to all registrants. Keynote speakers are Drs. Todd Golub (Director, Cancer Program of Broad Institute) and Stephen Chanock (Director, Division of Cancer Epidemiology and Genetics, NCI, NIH). See the program; further details will be posted when confirmed. Registration and abstract submission sites are open, with abstracts and poster sessions conducted as “retreat style.” Abstracts may be submitted that have been submitted/presented elsewhere or will be submitted elsewhere, without any copyright issue. We will NOT put any copyright on your abstract or officially publish your abstract. Top abstracts can be selected as short lectures. To learn more, please visit the MPE Meeting website. For questions, please feel free to contact the meeting Cochairs or the meeting Secretary, Ms. Martina Bragg.
From the Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
The Epidemiology and Genomics Research Program in NCI’s Division of Cancer Control and Population Sciences invites AACR-MEG members to register for upcoming webinars. To learn more about the EGRP’s webinar series and to register for upcoming webinars, visit the SeqSPACE Upcoming Topics and Speakers webpage.
Be Sure to See the AACR Blog: Cancer Research Catalyst!
See current scientific research updates in the AACR’s blog Cancer Research Catalyst, and learn how you can submit content!
Request for Proposals for Genome-wide Investigation of Late-effects Using the Childhood Cancer Survivor Study (CCSS) Cohort
The Childhood Cancer Survivor Study (CCSS) is an NCI-funded resource for the study of long-term survivors of cancer diagnosed during childhood and adolescence. Learn the details regarding the cohort.
Members of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute and CCSS investigators collaborated to conduct a genome-wide association study, initially intended to study the role of genetic susceptibility in the development of subsequent neoplasms as well as first primary childhood cancers using samples from the CCSS Biorepository. Genotyping was conducted for 5739 childhood cancer survivors diagnosed 1970-1986 (5324 are of European ancestry) using the Illumina HumanOmni5Exome microarray, with over 4.1 million loci passing quality control thresholds (based on locus and sample missing rates, sample heterozygosity, and sex discrepancies).
The CCSS leadership is now broadening the scope of this initiative to study the role of genetic susceptibility in the development of non-malignant, treatment-related outcomes in cancer survivors. Accordingly, CCSS is announcing a request for proposals to collaborate with CCSS and NCI investigators in the use of existing genome-wide association study (GWAS) data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for non-malignant treatment-related outcomes. Requests will be accepted on an ongoing basis and will be reviewed three times per year, in February, June, and October (cut-off for receipt of applications February 1, June 1, October 1).
Learn more details regarding the application process as well as the application for data access.
MEG Members Receive an Additional 5 Percent Discount on CEBP Accepted Manuscripts
MEG members receive a special 5 percent discount for publication fees only (not AuthorChoice) for articles accepted in Cancer Epidemiology, Biomarkers & Prevention (CEBP). This is in addition to the 5 percent discount given to all AACR members. Thus, MEG members receive a total discount of 10 percent. Just use the code “MEGAO2019” when receiving notification from the CEBP staff about author billing. See the information for authors for CEBP submissions. We look forward to receiving your submission.
CancerCareers Discounts Available
Be sure to check out www.cancercareers.org for career opportunities. MEG members now receive a 15 percent discount for all employment postings. Use the code MEGAD when submitting your advertisement to receive this special rate. You can also sign-up for job alerts and refine a job search by a specific research area, i.e. epidemiology; prevention. Look on the right side of the website for these options.
To Submit an Announcement for Consideration, Please Note:
Employment opportunities should be sent to cancercareers.org for posting consideration on that website. Please refer all questions regarding employment posting to
Postings of a non-employment nature may still be sent to firstname.lastname@example.org for review and possible future posting on the MEG Announcements.
Best regards from everyone at the AACR, and sincere appreciation for your